Clinical Trial Update: A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Boehringer Ingelheim is conducting a Phase 2 trial to evaluate BI 764524 for diabetic retinopathy, with the study status listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• BI 764524

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetic Retinopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING